The phagocytic activity of MDMs on KHOS/NP osteosarcoma cells was higher in cells pretreated with the CD47 antibody, exhibiting a 3.2-fold increase compared with those pretreated with the isotype antibody (p = 0.0016; Figure 5B,C). This evidence concerns the gene CD47 and osteosarcoma.